Cargando…

Viral Vector Vaccines against Bluetongue Virus

Bluetongue virus (BTV), the prototype member of the genus Orbivirus (family Reoviridae), is the causative agent of an important livestock disease, bluetongue (BT), which is transmitted via biting midges of the genus Culicoides. To date, up to 29 serotypes of BTV have been described, which are classi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiménez-Cabello, Luis, Utrilla-Trigo, Sergio, Calvo-Pinilla, Eva, Moreno, Sandra, Nogales, Aitor, Ortego, Javier, Marín-López, Alejandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823852/ https://www.ncbi.nlm.nih.gov/pubmed/33375723 http://dx.doi.org/10.3390/microorganisms9010042

Ejemplares similares

A protective bivalent vaccine against Rift Valley fever and bluetongue
por: Calvo-Pinilla, Eva, et al.
Publicado: (2020)

Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus
por: Utrilla-Trigo, Sergio, et al.
Publicado: (2020)

The Combined Expression of the Nonstructural Protein NS1 and the N-Terminal Half of NS2 (NS2(1-180)) by ChAdOx1 and MVA Confers Protection against Clinical Disease in Sheep upon Bluetongue Virus Challenge
por: Utrilla-Trigo, Sergio, et al.
Publicado: (2022)

Inhibition of Orbivirus Replication by Aurintricarboxylic Acid
por: Alonso, Celia, et al.
Publicado: (2020)

Modeling Arboviral Infection in Mice Lacking the Interferon Alpha/Beta Receptor
por: Marín-Lopez, Alejandro, et al.
Publicado: (2019)

Reverse genetics approaches: a novel strategy for African horse sickness virus vaccine design
por: Calvo-Pinilla, Eva, et al.
Publicado: (2020)

Pathological Characterization Of IFNAR(-/-) Mice Infected With Bluetongue Virus Serotype 4
por: Marín-López, Alejandro, et al.
Publicado: (2016)

Epizootic Hemorrhagic Disease Virus: Current Knowledge and Emerging Perspectives
por: Jiménez-Cabello, Luis, et al.
Publicado: (2023)

CD8 T Cell Responses to an Immunodominant Epitope within the Nonstructural Protein NS1 Provide Wide Immunoprotection against Bluetongue Virus in IFNAR(−/−) Mice
por: Marín-López, Alejandro, et al.
Publicado: (2018)

Recombinant Rift Valley fever viruses encoding bluetongue virus (BTV) antigens: Immunity and efficacy studies upon a BTV-4 challenge
por: Moreno, Sandra, et al.
Publicado: (2020)

Multiserotype Protection Elicited by a Combinatorial Prime-Boost Vaccination Strategy against Bluetongue Virus
por: Calvo-Pinilla, Eva, et al.
Publicado: (2012)

Nanoparticle- and Microparticle-Based Vaccines against Orbiviruses of Veterinary Importance
por: Jiménez-Cabello, Luis, et al.
Publicado: (2022)

Natural Selection of H5N1 Avian Influenza A Viruses with Increased PA-X and NS1 Shutoff Activity
por: Nogales, Aitor, et al.
Publicado: (2021)

Establishment of a Bluetongue Virus Infection Model in Mice that Are Deficient in the Alpha/Beta Interferon Receptor
por: Calvo-Pinilla, Eva, et al.
Publicado: (2009)

Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models
por: Lorenzo, María M., et al.
Publicado: (2023)

Mosquito Salivary Proteins and Arbovirus Infection: From Viral Enhancers to Potential Targets for Vaccines
por: Marín-López, Alejandro, et al.
Publicado: (2023)

Protection of IFNAR (−/−) Mice against Bluetongue Virus Serotype 8, by Heterologous (DNA/rMVA) and Homologous (rMVA/rMVA) Vaccination, Expressing Outer-Capsid Protein VP2
por: Jabbar, Tamara Kusay, et al.
Publicado: (2013)

Ns1 Is a Key Protein in the Vaccine Composition to Protect Ifnar(−/−) Mice against Infection with Multiple Serotypes of African Horse Sickness Virus
por: de la Poza, Francisco, et al.
Publicado: (2013)

A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model
por: Aksular, Mine, et al.
Publicado: (2018)

MVA Vectored Vaccines Encoding Rift Valley Fever Virus Glycoproteins Protect Mice against Lethal Challenge in the Absence of Neutralizing Antibody Responses
por: López-Gil, Elena, et al.
Publicado: (2020)

Breeding Sites of Bluetongue Virus Vectors, Belgium
por: Zimmer, Jean-Yves, et al.
Publicado: (2010)

Potential role of ticks as vectors of bluetongue virus
por: Bouwknegt, Chantal, et al.
Publicado: (2010)

Increasing the Safety Profile of the Master Donor Live Attenuated Influenza Vaccine
por: Hilimire, Thomas A., et al.
Publicado: (2020)

Animal viral diseases and global change: bluetongue and West Nile fever as paradigms
por: Jiménez-Clavero, Miguel Á
Publicado: (2012)

Monitoring of Putative Vectors of Bluetongue Virus Serotype 8, Germany
por: Hoffmann, Bernd, et al.
Publicado: (2009)

Economic comparison of the monitoring programmes for bluetongue vectors in Austria and Switzerland
por: Pinior, B., et al.
Publicado: (2015)

The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host
por: Calvo-Pinilla, Eva, et al.
Publicado: (2018)

Simulating spread of Bluetongue Virus by flying vectors between hosts on pasture
por: Græsbøll, Kaare, et al.
Publicado: (2012)

Vector competence is strongly affected by a small deletion or point mutations in bluetongue virus
por: van Gennip, René G. P., et al.
Publicado: (2019)

Vector competence of pre-alpine Culicoides (Diptera: Ceratopogonidae) for bluetongue virus serotypes 1, 4 and 8
por: Paslaru, Anca Ioana, et al.
Publicado: (2018)

Estimating the temporal and spatial risk of bluetongue related to the incursion of infected vectors into Switzerland
por: Racloz, V, et al.
Publicado: (2008)

Modelling bluetongue virus transmission between farms using animal and vector movements
por: Turner, Joanne, et al.
Publicado: (2012)

Saliva Proteins of Vector Culicoides Modify Structure and Infectivity of Bluetongue Virus Particles
por: Darpel, Karin E., et al.
Publicado: (2011)

Two-Host, Two-Vector Basic Reproduction Ratio (R (0)) for Bluetongue
por: Turner, Joanne, et al.
Publicado: (2013)

A Spatial Simulation Model for the Dispersal of the Bluetongue Vector Culicoides brevitarsis in Australia
por: Kelso, Joel K., et al.
Publicado: (2014)

Seasonal and spatial heterogeneities in host and vector abundances impact the spatiotemporal spread of bluetongue
por: Charron, Maud VP, et al.
Publicado: (2013)

Spatio-temporal optimization of sampling for bluetongue vectors (Culicoides) near grazing livestock
por: Kirkeby, Carsten, et al.
Publicado: (2013)

Potential vectors of bluetongue virus in high altitude areas of Yunnan Province, China
por: Duan, Ying Liang, et al.
Publicado: (2019)

Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine
por: Martínez-Sobrido, Luis, et al.
Publicado: (2018)

The genome of the biting midge Culicoides sonorensis and gene expression analyses of vector competence for bluetongue virus
por: Morales-Hojas, Ramiro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8441uqggvkodhnd2997u25rbql